Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06045962 · ClinicalTrials.gov registry record · NA
Optimal Stent Duration After Ureteroscopy
A NA study, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT06045962: Active NA study, sponsored by Mayo Clinic.
NCT06045962 is a NA study that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 172 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06045962, a NA study, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.
Interventions
- DEVICE Ureteral stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06045962
The ClinicalTrials.gov registry entry for NCT06045962 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ureteral stent is the first listed.
NCT06045962 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06045962 about?
NCT06045962 is a clinical study titled "Optimal Stent Duration After Ureteroscopy". The purpose of this study is to determine how soon ureteral stents can be safely removed following surgery.
What is the current status of trial NCT06045962?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2023-11-01. Estimated completion is 2026-09-01.
What interventions are being tested in trial NCT06045962?
The interventions under investigation include: Ureteral stent (DEVICE).
Who is sponsoring clinical trial NCT06045962?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.